Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 530

1.

Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.

Goei D, van Kuijk JP, Flu WJ, Hoeks SE, Chonchol M, Verhagen HJ, Bax JJ, Poldermans D.

Am J Cardiol. 2011 Feb 15;107(4):609-14. doi: 10.1016/j.amjcard.2010.10.021. Epub 2010 Dec 22.

PMID:
21185000
2.

Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.

Chong CP, Ryan JE, van Gaal WJ, Lam QT, Sinnappu RN, Burrell LM, Savige J, Lim WK.

Am J Cardiol. 2010 Sep 15;106(6):865-72. doi: 10.1016/j.amjcard.2010.05.012.

PMID:
20816130
3.

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.

Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.

N Engl J Med. 2005 Feb 17;352(7):666-75.

4.

Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.

Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, van den Meiracker AH, Boersma E, Schinkel AF, Kertai MD, van Sambeek MR, Poldermans D.

Am J Cardiol. 2006 Jul 1;98(1):111-5. Epub 2006 May 6.

PMID:
16784932
5.

Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.

Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermans D.

Am J Cardiol. 2008 Jan 1;101(1):122-6.

PMID:
18157978
6.

Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.

Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20.

PMID:
20381654
7.

Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction.

Sandhu S, Har BJ, Aggarwal SG, Kavanagh KM, Ramadan D, Exner DV; REFINE Investigators.

Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S86-9. doi: 10.1111/j.1540-8159.2008.02259.x.

PMID:
19250120
8.

Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke.

Jensen JK, Atar D, Kristensen SR, Mickley H, Januzzi JL Jr.

Am J Cardiol. 2009 Jul 15;104(2):287-91. doi: 10.1016/j.amjcard.2009.03.029. Epub 2009 May 13.

PMID:
19576362
9.

Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.

Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.

Am J Cardiol. 2007 Nov 15;100(10):1571-6.

PMID:
17996522
10.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
11.

N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration.

Ballotta A, Ranucci M, Kunkl A, El Baghdady H, Bossone E, Castelvecchio S, Frigiola A, Menicanti L, Di Donato M, Mehta RH.

Am J Cardiol. 2010 Mar 1;105(5):640-4. doi: 10.1016/j.amjcard.2009.10.047.

PMID:
20185010
12.

Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.

Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2007 Apr 15;99(8):1051-4. Epub 2007 Mar 6.

PMID:
17437726
13.

Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.

Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E, Elhendy A, de Jonge R, Karagiannis SE, Vidakovic R, Poldermans D.

Heart. 2007 Feb;93(2):226-31. Epub 2006 Aug 16.

14.

Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.

Schouten O, Hoeks SE, Goei D, Bax JJ, Verhagen HJ, Poldermans D.

J Vasc Surg. 2009 Feb;49(2):435-41; discussion 441-2. doi: 10.1016/j.jvs.2008.08.063. Epub 2008 Nov 22.

15.

The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.

Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.

Anesth Analg. 2009 Nov;109(5):1403-8. doi: 10.1213/ANE.0b013e3181b893dd.

PMID:
19843778
16.

NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease.

Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH.

Clin Nephrol. 2009 Apr;71(4):380-6.

PMID:
19356370
17.

Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.

Potocki M, Mair J, Weber M, Hamm C, Burkard T, Hiemetzberger R, Peters K, Jander N, Cron TA, Hess N, Hoffmann A, Gekeler H, Gohlke-Bärwolf C, Buser P, Mueller C.

Am J Cardiol. 2009 Aug 15;104(4):559-64. doi: 10.1016/j.amjcard.2009.04.023. Epub 2009 Jun 18.

PMID:
19660612
18.

N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.

Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.

J Am Soc Nephrol. 2007 Jan;18(1):321-30. Epub 2006 Dec 13.

19.

N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery.

Rajagopalan S, Croal BL, Bachoo P, Hillis GS, Cuthbertson BH, Brittenden J.

J Vasc Surg. 2008 Oct;48(4):912-7; discussion 917. doi: 10.1016/j.jvs.2008.05.015. Epub 2008 Jun 30.

20.

N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.

Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G.

Crit Care Med. 2007 Oct;35(10):2268-73.

PMID:
17717488

Supplemental Content

Support Center